Clindamycin Dosing for Hidradenitis Suppurativa
For an adult with hidradenitis suppurativa who cannot take doxycycline, use oral clindamycin 300 mg twice daily in combination with rifampin 300 mg twice daily for 8-12 weeks. 1
Recommended Dosing Regimen
The standard approach is clindamycin 300 mg twice daily combined with rifampin 300 mg twice daily for a treatment duration of 8-12 weeks 1. This combination is recommended as second-line treatment for mild-to-moderate disease or as first-line/adjunct treatment in severe disease 1.
Practical Administration Strategy
Start rifampin 300 mg twice daily alone for 7 days, then add clindamycin 300 mg twice daily 2. This staged approach may improve tolerability.
Clindamycin Monotherapy Alternative
If rifampin cannot be used, clindamycin 300 mg twice daily as monotherapy is an option, though the evidence is less robust 3. A retrospective study of 31 patients demonstrated significant reduction in disease severity scores with clindamycin monotherapy at this dose over 12 weeks 4. However, the 2019 North American guidelines note that data supporting clindamycin monotherapy are weaker than for the combination regimen 3.
Expected Outcomes
With the clindamycin-rifampin combination:
- Response rates of 71-93% have been reported 1
- 73% clinical response rate after 12 weeks in prospective studies 5
- 47% achieved complete remission in one cohort 6
- Maximum treatment effect typically occurs within 10 weeks 6
Critical Caveats
Relapse is common after treatment cessation. Among patients achieving complete remission, 59-61.5% experienced relapse at a mean of 4-5 months after stopping treatment 5, 6. The treatment can be repeated intermittently as needed 1.
Adverse effects occur in approximately 31% of patients, with diarrhea being the most common side effect 5, 6. About 7% discontinue treatment due to adverse events 7.
Antibiotic resistance is a concern with prolonged use, particularly with clindamycin monotherapy, which increases Staphylococcus aureus resistance rates 1. The combination regimen is preferred to reduce this risk.
Special Population: Pregnancy
In pregnant patients with HS requiring systemic antibiotics, oral clindamycin is safe for use (conditional recommendation, moderate quality evidence) 3. The 2025 guidelines specifically state that oral rifampin and clindamycin combination can be used in select patients with severe disease during pregnancy, though clindamycin monotherapy may also be considered with less robust supporting data 3.
Treatment Duration Considerations
- Standard course: 8-12 weeks 1
- Can be used as long-term maintenance therapy when appropriate 1
- May be used intermittently for disease flares
- Balance treatment benefit against antibiotic resistance risk 1
Monitoring
Monitor for gastrointestinal adverse effects, particularly diarrhea and Clostridioides difficile infection, which can occur up to 2 months after treatment cessation 8. Periodic liver and kidney function tests and blood counts should be performed during prolonged therapy 8.